Up-to-date guidance on the various treatment options available.
Reference1. Kloppenburg M, Kroon FP, Blanco FJ, et al. 2018 update of the EULAR recommendations for the management of hand osteoarthritis. Ann Rheum Dis. 2018 Aug 28. pii: annrheumdis-2018-213826. doi: 10.1136/annrheumdis-2018-213826. [Epub ahead of print].
Kloppenburg and fellow European researchers present an update to the 2007 European League Against Rheumatism (EULAR) guidelines for management of hand osteoarthritis (OA).1 Scroll through the slides for their rationale and 10 recommendations as well as take-home points for physicians.
Photo credit: ©Africa Studio/Shutterstock.com
EULAR, European League Against Rheumatism; NSAID, nonsteroidal anti-inflammatory drug; OA, osteoarthritis.
The EULAR recommendations are aimed at all health professionals who care for patients with hand OA. Physicians can use these recommendations to inform patients about their disease and to support shared decision-making. A slide deck is provided on the EULAR website to facilitate dissemination of the recommendations.